ABOUT THE AUTHORDebapriya Bhattacharya Debapriya Bhattacharya is a Content Producer at Hindustan Times
Goldstein B, Wieland D
A healthcare provider will determine eligibility based on your health
Guyatt, G., Weaver, B., Cronin, L., Dooley, J
Extended Clopidogrel Monotherapy Is Superior to DAPT in Bi-Risk ACS Patients: OPT-BIRISK Aug 28, 2023 by Nathan Gray, CRTonline.org An extended 9-month clopidogrel monotherapy regimen was superior to dual antiplatelet therapy (DAPT) in reducing clinically relevant bleeding without increasing ischemic events among acute coronary syndrome (ACS) patients at both high bleeding and ischemic risks (bi-risk) who had already completed 9-12 months of DAPT after drug-eluting stent (DES) implantation, randomized controlled trial data suggest
It's most appropriate for people dealing with specific injuries or conditions, not as a general wellness supplement